Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2017-08-25 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
监事会关于会计政策变更的说明
Audit Report / Information Classification · 95% confidence The document is a statement from the Supervisory Board regarding changes in accounting policies, referencing specific accounting standards issued by the Ministry of Finance of China. It discusses the impact of these changes on financial statement presentation but does not contain actual financial statements or comprehensive financial data. The document is explanatory and related to accounting policy changes rather than a full audit report or annual report. It is not a certification or a brief announcement but a detailed explanation of accounting policy changes by the supervisory board. This fits best under Audit Report / Information (AR), which includes applied accounting principles and related disclosures outside of full annual reports.
2017-08-25 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about changes in accounting policies, specifically referencing new accounting standards issued by the Ministry of Finance of China and their impact on financial statement presentation. It includes details about the nature of the changes, their effective dates, and opinions from independent directors and the supervisory board. The document does not contain full financial statements or comprehensive financial performance data, but rather focuses on the policy change announcement and its implications. The length is relatively short (2430 characters), and it is not a full annual or interim report. It is not a certification letter or a simple report publication announcement. The content fits best with a Regulatory Filing (RNS) as it is a formal regulatory announcement about accounting policy changes without full financial data or report content.
2017-08-25 Chinese
2017年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2017 半年度报告摘要' which translates to '2017 Half-Year Report Summary'. It contains detailed financial data for the first half of 2017, including total assets, net profit, earnings per share, and other financial metrics. It also includes a management discussion and analysis section describing business operations, product development, acquisitions, and strategic initiatives during the reporting period. The document is about 4451 characters long, which is sufficient to contain substantive financial data and analysis. It is not merely an announcement or a certification but a comprehensive interim report covering a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-25 Chinese
2017年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the management and actual use of funds raised by the company through a non-public stock issuance. It includes specifics on the amount raised, the use of funds, compliance with regulatory requirements, and a detailed table of fund usage. The document references regulatory guidelines from the China Securities Regulatory Commission and Shanghai Stock Exchange related to the management and use of raised funds. The content focuses on the status and use of capital raised, including investment projects, cash management, and compliance with fundraising regulations. This matches the description of a Capital/Financing Update, which covers updates on company fundraising and capital structure changes. The document is not an announcement of a report but the report itself, given its length (5443 characters) and detailed financial data on fundraising usage. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2017-08-25 Chinese
高级管理人员薪酬管理办法
Remuneration Information Classification · 95% confidence The document is a detailed policy on senior management compensation, including principles, salary structure, performance-based pay, and administrative rules. It is a governance-related document outlining internal rules and practices for executive remuneration. It does not contain financial statements, audit information, or regulatory announcements. It is not a report or announcement of financial results or voting. The content fits the definition of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2017-08-25 Chinese
独立董事关于第九届董事会第十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from the independent directors of a company regarding various matters discussed at the ninth board's tenth meeting. It includes opinions on capital reserve conversion to share capital, use of raised funds, cash management, senior management remuneration policy, and accounting policy changes. The document references compliance with regulatory guidelines and company bylaws but does not contain financial statements or detailed financial data. It is a governance-related document focused on board and management matters rather than a full report or announcement of financial results. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification letter, so it is not RPA or RNS.
2017-08-25 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.